Protara Therapeutics, Inc.
SEC CIK 1359931 · TARA · last insider filing 2026-06-16
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Beshar Luke M | Director | filed 2020 - 2026 |
| Sargen Gregory | Director | filed 2020 - 2026 |
| Garceau Roger | Director | filed 2020 - 2026 |
| Levy Richard S | Director | filed 2020 - 2026 |
| Smith Cynthia | Director | filed 2021 - 2026 |
| Flannelly Barry P | Director | filed 2020 - 2026 |
| Huang Jane | Director | filed 2021 - 2026 |
| Solomon Michael Edward | Director | filed 2020 - 2026 |
| Shefferman Jesse | Director · CEO and President | filed 2020 - 2026 |
| Braunstein Scott | Director | filed 2020 - 2020 |
| Haines Timothy | Director | filed 2014 - 2019 |
| Freund John Gordon | Director | filed 2014 - 2019 |
| Noyes Timothy P | Director · President and CEO | filed 2014 - 2019 |
| Deerfield Management Company, L.P. (Series C) | Director | filed 2014 - 2018 |
| Leff Jonathan S | Director | filed 2017 - 2018 |
| Flynn James E | Director | filed 2014 - 2018 |
| Bohlin Garen G | Director | filed 2014 - 2018 |
| Canute Scott A | Director | filed 2015 - 2018 |
| Hastings Paul J | Director | filed 2016 - 2018 |
| Kingsley Stuart A | Director | filed 2015 - 2018 |
| Birner Hubert | Director | filed 2014 - 2018 |
| Deerfield Mgmt L.P. | Director | filed 2014 - 2017 |
| Deerfield Partners, LP | Director | filed 2017 - 2017 |
| Deerfield International Master Fund, L.P. | Director | filed 2017 - 2017 |
| Deerfield Special Situations Fund, L.P. | Director | filed 2014 - 2017 |
| Deerfield Private Design Fund III, L.P. | Director | filed 2014 - 2017 |
| Deerfield Mgmt III, L.P. | Director | filed 2014 - 2017 |
| Deerfield Private Design Fund IV, L.P. | Director | filed 2017 - 2017 |
| Deerfield Mgmt IV, L.P. | Director | filed 2017 - 2017 |
| TVM Life Science Ventures VI LP | Director | filed 2014 - 2017 |
| TVM Life Science Ventures VI Gmbh & Co KG | Director | filed 2014 - 2017 |
| O'Leary Brendan | Director | filed 2014 - 2016 |
| Phelps Gregory D | Director | filed 2014 - 2015 |
| Kobyzev Dmitry | Director | filed 2014 - 2015 |
| Prism Venture Partners V L P | Director | filed 2014 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Conkling William | Chief Commercial Officer | filed 2025 - 2026 |
| Zummo Jacqueline | Sr. Vice President, Research | filed 2020 - 2026 |
| Fabbio Patrick | Chief Financial Officer | filed 2023 - 2026 |
| Fry Hannah | VP, Controller | filed 2022 - 2026 |
| Nicacio Leonardo Viana | Chief Medical Officer | filed 2025 - 2026 |
| Bandari Jathin | Chief Medical Officer | filed 2022 - 2024 |
| Davis Blaine | Chief Financial Officer | filed 2020 - 2022 |
| Olivo Martin Sebastian | Chief Medical Officer | filed 2021 - 2021 |
| Casoy Julio | Chief Medical Officer | filed 2020 - 2020 |
| Burke Steven Keith | Sr. VP & Chief Medical Officer | filed 2014 - 2019 |
| Gottlieb Daniel Philip | VP Marketing & Business Dev't | filed 2014 - 2019 |
| Eldridge, George Arthur | Sr VP, CFO, Treasurer, Secy | filed 2014 - 2019 |
| Toner E. Scott | Senior VP of Marketing | filed 2015 - 2019 |
| Kowalsky Matthew Paul | VP, Legal and Secretary | filed 2017 - 2019 |
| Hartman Bradley J | VP, People | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.